Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.
about
MiR-122 in hepatitis B virus and hepatitis C virus dual infectionAnalysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countriesAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Current hepatitis B treatment guidelines and future research directions.Occult HBV infection: a faceless enemy in liver cancer development.Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece.Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers.Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.Epidemiology of hepatitis C virus infection in highly endemic HBV areas in China.Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.Genetic variation in interleukin 28B and response to antiviral therapy in patients with dual chronic infection with hepatitis B and C viruses.The influence of hepatitis B and C virus coinfection on liver histopathology in children.Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population.Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virusBurden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India.Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report.Collagenogenic invasion in the livers of viral hepatitis patients.Coinfections of the Respiratory Tract: Viral Competition for Resources.Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study.Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.Characteristics of hepatitis B infection in a sample of omani patients.Correlation of serum hepcidin levels with disease progression in hepatitis B virus-related disease assessed by nanopore film based assayHepatitis B virus infection in Chinese patients with hepatitis C virus infection: prevalence, clinical characteristics, viral interactions and host genotypes: a nationwide cross-sectional studyManagement of patients co-infected with HBV and HCV.HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infection.Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection.Treatment of special populations with chronic hepatitis B infection.The management of chronic hepatitis B in Asian Americans.Oral fluid and hepatitis A, B and C: a literature review.Do hepatitis B virus and hepatitis C virus co-infections increase hepatocellular carcinoma occurrence through synergistically modulating lipogenic gene expression?A computational approach to identify point mutations associated with occult hepatitis B: significant mutations affect coding regions but not regulative elements of HBV.Safely treating hepatitis C in patients with HIV or hepatitis B virus coinfection.Management of HCV in cirrhosis-a rapidly evolving landscape.Emerging challenges in managing hepatitis B in HIV patients.Reactivation of Hepatitis C Virus and Its Clinical Outcomes in Patients Treated with Systemic Chemotherapy or Immunosuppressive Therapy.Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirinPotential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV.Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature.Effect of Liver Disease on Hepatic Transporter Expression and Function.
P2860
Q27008894-77C88C97-4CC9-40E4-A5CA-28EFF9009453Q28830093-F5BFB864-7448-4F43-B117-9B97F6E2549FQ30391932-6E694791-58FB-4AB2-93F5-81128F153417Q30487002-FE57696D-2F52-43E9-B80A-4FF609232100Q33584773-23733D01-02AC-4DED-8876-03537E54D3D1Q33590821-F1869201-AD5F-4A96-AAF5-DACA0614A82BQ33833241-F1844CE8-5768-428C-9D6C-9FBF5A9F0012Q34425267-E626BD92-1DA6-4BE2-90E6-3B6ED41C24E0Q34571364-DB1B7776-D248-46BA-A891-1C494DDC472EQ34577157-6993CCEB-0D98-44CB-A7B5-C121AEA6318DQ34630032-FCF625F5-027C-4075-AA0F-F39F73F804F8Q35023484-0612BE7B-4720-4CF4-8895-66F2311FF236Q35100262-9556519F-41DD-4621-A439-E50D0DBD4B74Q35793834-49E7683C-9C4E-4241-BCAB-E2F706855C70Q35833159-297C830E-43D5-44D1-9FE2-36F4A7F92027Q35904838-C97094AE-9C21-4C97-8E89-3774767280D9Q35949952-50011446-2042-49A3-B90E-F545C6E428AEQ36014457-0E10A42E-93B6-45AB-BC99-C43BBA02E17BQ36022472-677A5CB9-B1D8-4E19-8F0A-51E9D89FA484Q36555268-C6557FF6-411F-4A0B-A1AC-9133E1BD7ED4Q37060330-E305FADD-4F13-4E49-83FD-6EADE1B267A2Q37109576-B1793109-8619-4996-A062-2BE4A540E635Q37303512-A219434A-D565-4D33-B589-86193E4F0082Q37356018-F4749B8C-0AEC-4991-8949-A61820D5B98EQ37503341-E4B6E69B-181C-4FD4-BAA9-8A73EBD8992DQ37529062-B6E33095-007C-4808-ACBB-BDC37B03AF24Q37855732-F154D668-AFB2-4378-9C74-3E01DE5BB0C0Q37886158-677052DA-6B1B-4687-A97E-7BB04E9AAC67Q37936321-04713D37-240F-44B8-87D8-F95C6DAEB2B6Q37970474-1D99192C-6D76-4F78-A514-22C48534FB2DQ38001126-A93C7CDB-897C-4C41-B8B3-679C4429453CQ38367253-8F12A2B9-20AB-4FC0-B9BC-0C3A3F87A171Q38392453-9BAB3C15-7745-42EE-982A-44C454DF7FEDQ38432047-BE92F606-68B7-4BF2-985A-8598B609C4B8Q38544189-85E91DFA-730A-4CE3-AB71-4A4EC78C6C34Q38657207-869E2154-8EC7-45C5-97C9-DE28087BF922Q38679899-07A435C8-2B54-4266-A0B9-3D2581D08B19Q38724160-E516D9F2-400F-46C1-82C4-CD94497C4D88Q38793776-BEAAFDC5-022A-44BE-8EC7-E91247369534Q38808182-EF6BB4E3-8AE7-44FD-80B3-DAE5E592735D
P2860
Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis B virus/hepatitis C ...... al interactions and treatment.
@en
Hepatitis B virus/hepatitis C ...... al interactions and treatment.
@nl
type
label
Hepatitis B virus/hepatitis C ...... al interactions and treatment.
@en
Hepatitis B virus/hepatitis C ...... al interactions and treatment.
@nl
prefLabel
Hepatitis B virus/hepatitis C ...... al interactions and treatment.
@en
Hepatitis B virus/hepatitis C ...... al interactions and treatment.
@nl
P2860
P1476
Hepatitis B virus/hepatitis C ...... al interactions and treatment.
@en
P2093
Chi-Jen Chu
Shou-Dong Lee
P2860
P304
P356
10.1111/J.1440-1746.2008.05384.X
P577
2008-04-01T00:00:00Z